For instance, reprogramming macrophages to switch from the tumor-promoting M2 phenotype to the tumor-inhibiting M1 phenotype can be achieved by using viral vectors, which deliver genes encoding cytokines or chemokines activating the M1 phenotype, such as IFN-γ and IL-12 [122, 150]. This evidence concerns the gene IFNG and neoplasm.